Peptides DB
Research-centric peptide and protocol reference hub
Study 9 of 9Melanotan II literatureeuropepmc · Observational2026

Association of central α-klotho with dopaminergic and melanocortin receptors on feed intake regulation in chicken.

The study found that α-klotho influences feed intake in chickens through interactions with certain dopaminergic and melanocortin receptors, but the practical implications of these findings are not yet clear.

Read at europepmcAdd to compare

Where it sits

this study against the rest of the melanotan ii corpus
3
Preclinical
6
Observational · this one
0
Open-label
0
Randomised
0
Reviews

Summary and findings

This study examined the association of central α-klotho with dopaminergic and melanocortin receptors in regulating feed intake in 264 meat-type chickens across six experiments. Various receptor antagonists were administered, and feed intake was measured up to 120 minutes post-injection. The results indicated that certain receptor antagonists influenced the α-klotho-induced reduction in feed intake.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as europepmc supplied them

This study aimed to detemine association of central α-klotho with dopaminergic and melanocortin receptors on feed intake regulation in chicken. 264 meat-type chicken were included 6 experiments, each containing 4 groups. In experiment 1, the group (A) received injections of saline, group (B) SCH23390 (D<sub>1</sub> receptor antagonist, 5 nmol), group (C) α-klotho (4 µg) and group (D) co-injection of the SCH23390 + α-klotho. In experiments 2-6, AMI-193 (D<sub>2</sub> receptor antagonist, 5 nmol), NGB2904 (D<sub>3</sub> receptor antagonist, 5 nmol), L-741,742 (D<sub>4</sub> receptor antagonist, 5 nmol), SHU9119 (nonselective MC<sub>3</sub>/MC<sub>4</sub> receptor antagonist, 0.5 nmol) and MCL0020 (selective MC<sub>4</sub> receptor antagonist, 0.5 nmol), instead of the SCH23390. Then feed intake determined up to 120 minutes post injection. Based on the results, D<sub>1</sub> receptor antagonist decreased α-klotho-induced hypophagic effect compared to control group (P < 0.05). Also, D<sub>2</sub> receptor antagonist decreased α-klotho-induced hypophagic effect compared to control group (P < 0.05). Co-injection of the D<sub>3</sub> receptor antagonist + α-klotho had no effect on α-klotho-induced hypophagia (P > 0.05). Co-injection of the D<sub>4</sub> receptor antagonist + α-klotho had no effect on α-klotho-induced hypophagia (P > 0.05). Co-injection of the nonselective MC<sub>3</sub>/MC<sub>4</sub> receptor antagonist decreased α-klotho-induced hypophagic effect compared to control group (P < 0.05). Co-injection of the selective MC<sub>4</sub> receptor antagonist decreased α-klotho-induced hypophagic effect compared to control group (P < 0.05). Findings suggested α-klotho-induced hypophagia mediates by D<sub>1</sub> and D<sub>2</sub> dopaminergic as well as MC<sub>3</sub> and MC<sub>4</sub> melanocortin receptors in neonatal broiler chicken.

Elsewhere in the Melanotan II corpus

CLow dose systemic AAV-exendin-4 gene therapy for Prader-Willi syndrome and dietary obesity.europepmc · 2026 · Not reported in abstract.AnimalBFive primary melanomas in situ in a patient with recent tanning bed use, melanotan exposure, and anabolic hormone use.europepmc · 2026 · n=1 · Not reported in abstract.HumanCMelanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for foodbiorxiv-preprint · 2022 · n=20 · Not reported in abstract.AnimalBChanges in Oral Mucosa Associated with Melanotan II Injections: A Case Report.PubMed · 2026 · Not reported in abstract.HumanDSemantic Scholar search for Melanotan IISemanticScholarDBarbie drug identification: Not a child's play.PubMed · 2024 · 30% purity of Melanotan II.